Out Fox The $treet

Update - Oct. 30, 2025  Roblox reported massive Q3'25 growth with bookings up 70% to $1.9 billion. The stock is down roughly 10% with the market lost focusing on GAAP revenue and net loss metrics, which don't fully incorporate billings.  Q3 Net loss of $257M Revenue of $1.4B (+23.9% Y/Y)  misses by $300M . Bookings up 70% Y/Y to $1.9B Average Daily Active Users 151.5M (+70% Y/Y) The mobile gaming platform reported bookings grew nearly $500 million above the record levels in Q2. The market cap has dipped to $82 billion and the company is likely to see 2026 bookings estimates reach $8+ billion next year, so the stock trades at ~10x forward bookings.  Roblox isn't historically cheap, but this level of bookings growth will warrant higher valuation multiples.  Original article posted on Sept. 9  Roblox remains a top growth story, but the stock is now priced for perfection after a major run. The immersive gaming platform faces more child safety lawsuits and ...

Update - Oct. 28, 2025  The big AI deals just keep coming. -TeraWulf shares jumped 20% in Tuesday morning trading after the company said it struck a 25-year AI compute joint venture with Fluidstack to build 168 megawatts of high-performance computing ("HPC") capacity at its Texas campus. -The deal represents about $9.5B in contracted revenue to the joint venture, with TeraWulf holding a 51% stake. It's possible the lease term may be shortened to 20 or 15 years. The total cost of the project is expected to be $8M-$10M per MW of critical IT load. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » Original article posted on Oct. 9  TeraWulf is quickly transitioning from bitcoin mining to a digital infrastructure provider, securing major AI hosting contracts and Google backing. WULF's expanded deal with Fluidstack and a $3.2 billion Google commitment position the company for $...

Update - Oct. 23, 2025 Intel  beats weak guidance and hardly grows during an AI chip boom, market cheers anyway with weak guidance for Q4. The market just seems to get dumber and dumber. -Q3 Non-GAAP EPS of $0.23 beats by $0.22. -Revenue of $13.7B (+3.2% Y/Y) beats by $560M. Q4 Guidance  Revenue guidance of $13.4B vs. consensus of $13.37B EPS guidance of $0.08 consensus of $0.08 Original article posted on Oct. 7 Intel has surged despite no fundamental improvements in its foundry business or AI capabilities, making the rally appear irrational. The chip company has signed deals with Nvidia and the U.S. government for cash infusions provides liquidity but do not solve the lack of HPC foundry customers or AI solutions. IFS continues to report massive losses, and competitors like AMD and TSMC show no signs of meaningful collaboration with INTC on premium chips. The stock is extremely expensive at over 30x '27 EPS targets, investors are advised to use the rally to exit positions as ...

Update - Oct. 22, 2025 Avride gets a $375 million investment from Nebius Group (NBIS) and Uber Tech. (UBER). The company owned by Nebius is actively planning to launch a robotaxi service with Uber in Dallas and already has delivery robots in Jersey City, Austin and Dallas.  Nebius has slipped below $100 as the hot stocks continue to selloff this week. The stock is cheap compared to the large AI growth opportunities in the next few years with Avride and other investments mostly overlooked.  The stock definitely has some short-term trading risk on whether the gap is closed all the way to just above $60. The Microsoft home-run deal would seem to provide more support, but possibly not.  Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » Update - Oct. 2, 2025 Nebius jumps over $120 on more details from the big Microsoft deal. The market appears overly concerned Microsoft isn't...

  Hims & Hers Health launched menopause and low testosterone products in the last month, expanding its addressable market and supporting its $6.5 billion 2030 revenue target. Recent product launches, including at-home lab testing, are expected to boost ARPU and drive significant revenue growth for HIMS in coming years. The stock market over reacted to planned stock sells by the CEO. Current weakness in HIMS shares presents a buying opportunity, with the stock trading at just 4x projected 2026 sales and robust long-term potential. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » Hims & Hers Health, Inc.  ( NYSE: HIMS ) launched a new product to market excitement, yet the stock ended last week lower due to confusion related to the CEO. The online health and wellness platform continues to build  out a strong lineup of new health products contributing to the expecte...

GitLab Inc. remains a rumored buyout target, but a $60 offer undervalues its growth and strategic position. The DevSecOps company benefits from generative AI, driving software development complexity demand and 20%+ revenue growth. The company's strong gross margins, cash flow, and $1.2 billion cash balance reduce pressure to accept a low-premium buyout. GTLB stock investors should view current multi-year lows as a buying opportunity, with upside potential from both independence and a higher buyout offer. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » GitLab Inc. ( NASDAQ: GTLB ) is constantly rumored as a buyout candidate, yet companies never seem interested in paying a very big premium. The DevSecOps company continues to benefit from generative AI leading to software development momentum and  growing demand. My  investment thesis  is more Bullish on the stock with or...

Update - Oct. 14, 2025 The stock is surging on more news of working on quantum computers, though indie Semi. hasn't announced anything material revenue related. The stock has soared to new highs regardless.  Original article posted on Aug. 13  indie Semiconductor is entering a major ADAS ramp, with a $7.1B backlog and a goal of $800M sales by 2028. The auto tech company is reporting stable financials, with manageable losses and a strong cash position, giving time for product ramps to materialize. indie Semiconductor is expanding into humanoid robots and quantum communications, adding exciting optionality beyond core auto tech, with real orders already secured. At just 3x conservative 2026 sales estimates, the stock remains ultra cheap with substantial upside as ADAS ramps and new markets develop. indie Semiconductor, Inc.  ( NASDAQ: INDI ) has had a painful year until recently. The auto tech company has a massive backlog with promising ADAS orders while quick expansions i...

Update - Oct. 7, 2025 Archer Aviation has soared here on speculation of a partnership with Tesla, though such a move doesn't make a lot of sense. The stock likely hits resistance here at $13.50 again.  Original article posted on Aug. 14 Archer Aviation Inc. continues to unlock massive global opportunities in the air taxi and defense sectors. The company has disappointed the market with recent aircraft design changes and pilot testing, but progress towards commercialization is still being made. Strategic partnerships, especially with Anduril, and international contracts provide near-term revenue and position Archer for commercial and defense market growth. ACHR stock trades far below the market values of companies with similar market opportunities in the eVTOL and defense space. While  Archer Aviation, Inc.  ( NYSE: ACHR ) has seemed like the company operates in a hot space, the stock has traded mostly flat all year. The eVTOL aircraft manufacturer pushing into the defense...

Updated - Oct. 2, 2025 Upstart might have some support here around $50 after BTIG caused the crash from $60 based on faulty delinquency data . The stock hasn't actually rallied on this news suggesting the negative momentum could keep Upstart under pressure.  Update - Sept. 24, 2025 Despite the rate cute, Upstart is trading down at recent lows. If the stock breaks $60 tomorrow, watch out below.  Original article posted on Aug. 6 Upstart reported a strong Q2 due to a big boost in loan conversions, but questions remain about sustainability and lack of consistent volume growth. The AI lending platforms expansion into auto and home loans is promising, but funding partners are lacking. The stock trades at 35x 2026 EPS targets, making Upstart expensive for uncertain funding growth. I remain Neutral on Upstart; consider buying on weakness or a breakout above $80 only if supported by rate cuts or major funding news. Looking for a portfolio of ideas like this one? Members of Out Fox The...

Update - Sept. 19, 2025 As predicted, CoreWeave has started recovering after the irrational sell off heading into the lock-up expiration. The stock is back to $125 now and Loop Capital just initiated the stock with a $165 price target based only on a 10x '27 EBITDA target of $12.8 billion. The firm forecasts '27 revenues of $17.9 billion.  The stock is probably an easy ride back to prior highs with booming AI data center demand.  Update - Aug. 27, 2025 CoreWeave has seen the momentum change with the Cantor buy rating and $116 price target. The lock-up expiration flush should be over.  Original article posted on Aug. 15 CoreWeave, Inc.'s stock collapse post-acquisition and early lock-up creates a compelling buying opportunity below $100, flipping the original thesis. The AI Cloud company reported strong Q2 results with 210% revenue growth, $1B+ quarterly sales, and a record of $30.1B backlog, showing massive demand and scalability. Despite heavy capex and $11B of debt, Cor...

  Hims & Hers Health has traded very volatile over the last year as the market misunderstands the business opportunity beyond GLP-1s and weight-loss drugs. The online health and wellness faces FDA scrutiny, but this is industry-wide and not unique to the company. The platform is rapidly growing subscribers, launching new offerings, and targeting large under-penetrated markets domestically and internationally on a path to hitting a $6.5B 2030 sales target. The stock trades at a low valuation relative to its growth at only 4x '26 sales targets, making current levels a compelling buying opportunity. Hims & Hers Health, Inc. ( NYSE: HIMS ) has hit a bumpy ride over the last year, with the stock stuck in a range from $40 to $70. The online health and wellness platform has faced a lot of questions regarding compounding GLP-1s, with the latest  news being a letter from the FDA. My  investment thesis  remains ultra Bullish on the stock, as the company moves forward w...

Update - Sept. 9 AST SpaceMobile appears headed back down to $25. The UBS downgrade following the Starlink purchase of Echostar spectrum is the final straw.  Shares of AST SpaceMobile slipped nearly 8% during early trading hours on Tuesday as UBS downgraded the company to Neutral from Buy, mainly due to increasing competitive concerns. UBS said ASTS Will be a leader in the emerging space-to-cellular  broadband market on the back of its technology, carrier relationships and ability to link unmodified devices using multiple spectrum bands. The brokerage firm also lowered its price target to $43 from a previous price target of $62. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » Original article posted on Aug. 13  AST SpaceMobile continues to miss satellite launch targets, delaying commercial service and raising doubts about execution. Competitive threats from Starlink an...

Update - Sept. 4, 2025 C3.ai still hasn't explained the reason for so much sales to just disappear during FQ1 while the FQ2 guidance for $72-$80M is only a small bounce back. The enterprise AI software company did announce a promising new CEO is a sign this could be the bottom.  -FQ1 Non-GAAP EPS of -$0.37 misses by $0.16. -Revenue of $70.26M (-19.4% Y/Y) Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » Original article posted on July 1 C3.ai is experiencing strong overall growth, especially in professional services, but subscription revenue growth remains muted and needs improvement for stronger investor confidence. The company’s partnership with Microsoft Azure and a major U.S. Air Force contract expansion highlight significant future growth catalysts and validation of its AI solutions. Despite persistent operating losses, C3.ai’s robust $743 million cash balance and low EV/Sal...

  SentinelOne delivered strong FQ2 results, with net new ARR rebounding to $53M and total ARR surpassing $1B, alleviating prior growth concerns. AI-driven products like Purple AI and Prompt Security are driving adoption, reducing security events, and positioning SentinelOne as a leader in enterprise AI security. The cybersecurity company now has positive operating margins and boasts $1.2B in cash, supporting continued innovation and strategic acquisitions. The stock valuation remains deeply discounted at 6x forward sales versus peers, offering compelling risk/reward as growth and multiple expansion potential remain high. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » SentinelOne, Inc.  ( NYSE: S ) rallied somewhat after a  strong FQ2 earnings report . The cybersecurity company has constantly been overlooked despite strong growth with a shifting focus on cloud and AI. ...

  PayPal is positioned for strong growth with its PYUSD stablecoin and the PayPal World global wallet platform as major catalysts. The company is leveraging its vast user base and partnerships to expand PYUSD's adoption, aiming to capture a larger share of the potential for a multi-trillion-dollar stablecoin market. PayPal is delivering solid financial results, with 5% revenue growth, 18% EPS growth, and aggressive share buybacks enhancing shareholder value. The stock only trades at 12x '26 EPS targets, and upcoming catalysts make me ultra bullish on the stock's long-term upside potential. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » PayPal Holdings, Inc.  ( NASDAQ: PYPL ) has a slow and steady growth profile with a major catalyst opportunity. The fintech continues progressing towards a dynamic commerce platform led by crypto via a leading stablecoin and an expansion to ...

  Viking Therapeutics' stock plunged over 40% after misunderstood Phase 2 oral weight-loss drug data, despite results showing strong short-term efficacy versus market leaders. The Phase 2 trial demonstrated 12.2% weight loss in 13 weeks, with progressive results and potential for further improvement with longer dosing periods. Concerns over high discontinuation and GI side effects are noted, but these issues are manageable and expected to be addressed in Phase 3 studies. The market's reaction is a major overreaction; I remain ultra bullish on VKTX stock, as the investment thesis is de-risked and the pipeline is well-funded for future growth. Viking Therapeutics, Inc.  ( NASDAQ: VKTX ) plunged after the market wildly misinterpreted Phase 2 data for a key weight loss drug. The biotech continues to progress to a pivotal Phase 3 study while de-risking the strong pipeline. My  investment thesis  remains ultra Bullish on the stock, especially after Viking Therapeutics fell...

Update - Aug. 18, 2025 SoundHound AI has quickly rolled over as the market starts understanding the limited organic growth doesn't warrant a stock trading at 40x sales targets. The stock likely closes the gap down to $11.06 from Aug. 7.  Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » Original article posted on Aug. 13 SoundHound AI reported record Q2 revenues, but guidance for the second half of 2025 was weaker, raising concerns about sustainable growth. The company continues to report limited organic growth, with much of the recent revenue boost attributed to acquisitions rather than core business expansion. Despite a $6.5 billion valuation and claims of a large pipeline, actual progress in key verticals like restaurants and autos appears slow and unclear. I remain ultra bearish on SOUN due to its rich valuation and lack of a compelling, transparent growth story for long-term ...

Update - July 25, 2025 Nextdoor surged following the launch of the NEXT platform and switch of the ticker to "NXDR", but the stock has sold off the last 4 days providing an ideal entry point.  Original article posted on June 4 Nextdoor Holdings, Inc. trades near cash value, presenting a compelling risk/reward as it prepares to launch its transformative NEXT platform. Management paused monetization and user growth to focus on NEXT, temporarily depressing revenue but setting up for a major turnaround. NEXT aims to deliver hyper-local content, professional news, and AI-driven recommendations, addressing past engagement and monetization challenges. The stock trades at less than 1x EV/S targets due to a strong cash position, limiting downside risk while the upcoming platform relaunch offers significant upside potential. Just as  Nextdoor Holdings, Inc.  ( KIND ) is set to launch a new user interface, the stock trades at all-time lows. Despite a promising turnaround in place, t...